This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chase, J J Articles by Ribi, E Search for Related Content PubMed PubMed Citation Articles by Chase, J J Articles by Ribi, E

 Previous Article  |  Next Article 

Infect Immun. 1986 September; 53(3): 711-712

Effect of monophosphoryl lipid A on host resistance to bacterial infection.

ABSTRACT

The ability of monophosphoryl lipid A (MPLA) to enhance nonspecific host resistance to bacterial infections was studied. Mice were treated with MPLA prior to intraperitoneal challenge with Escherichia coli or Staphylococcus epidermidis. Animals received additional MPLA for 2 days postinfection, and survival rates were determined. Ten micrograms of MPLA per mouse significantly improved the survival of animals infected with either bacterial species. Dose-response studies showed significant MPLA-induced protection at doses of 6 micrograms/kg against E. coli challenge and 60 micrograms/kg against S. epidermidis challenge.

This article has been cited by other articles:

• Luxameechanporn, T., Kirtsreesakul, V., Klemens, J., Khoury, P., Thompson, K., Naclerio, R. M. (2005). Evaluation of Importance of Toll-like Receptor 4 in Acute Streptococcus pneumoniae Sinusitis in Mice. Arch Otolaryngol Head Neck Surg 131: 1001-1006 [Abstract] [Full Text]  
• Neely, A. N., Orloff, M. M., Holder, I. A. (1996). Disparities in efficacies of anti-LPS agents in burned mouse models of LPS intoxication versus Gram-negative sepsis. Innate Immunity 3: 111-117 [Abstract]  
• Neely, A.N., Orloff, M.M., Imwalle, A.R., Holder, I.A. (1995). A murine model for studying endotoxemia and the efficacy of anti-LPS agents in an immunocompromised host. Innate Immunity 2: 115-120 [Abstract]